Crossmark

Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study

Crossref DOI link: https://doi.org/10.1016/j.nefro.2024.06.002

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Islek, Tugba

Mirioglu, Safak

Gursu, Meltem

Kazancioglu, Rumeyza

Demirel, Metin

Selek, Sahabettin

Elcioglu, Omer Celal
Funding

Funding for this research was provided by:

Bezmialem Vakif University
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-06-09
More Information

This article is maintained by: Elsevier

Article Title: Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2024.06.002

Content Type: article

Copyright: © 2024 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below